• letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: AIVITA Biomedical, Inc. From: prnewswire.com AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial. The patient has received the eighth and final dose of the study therapy under the guidance of Principal Investigator Dr. Lisa Abaid ...
    The post AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial appeared first on Let Life Happen.